Multilayer tablets and their drug release kinetic models for oral controlled drug delivery system

Middle East Journal of Scientific Research

Volumn 16, Issue 6, 2013, Pages 782-795

  Yadav, Ghanshyam ^a   Bansal, Mayank ^a   Thakur, Nishi ^a   Sargam, ^a   Khare, Pragati ^a  

^a MEERUT INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Controlled release; Drug delivery; Modelling; Multilayered matrix system

Indexed keywords

EID: 84885987362     PISSN: 19909233     EISSN: 19998147     Source Type: Journal    
DOI: 10.5829/idosi.mejsr.2013.16.06.75176     Document Type: Article

References (87)

1. Curry, S.H., 1983. Novel drug delivery systems, 2nd ed.: John Wiley & Sons, Ltd.
2. Green, P.G., 1996. Iontophoretic delivery of peptide drugs. J. Control. Release, 41: 33-48.
3. Kim, C.J., 2000. Coated Tablet with Long Term Parabolic and Zero-Order Release Kinetics. U.S. Patent 6,110,500, 29 August 2000.
4. Sershen, S. and J. West, 2002. Implantable, polymeric systems for modulated drug delivery. Adv. Drug Dehv. Rev., 54: 1225-1235.
5. Vandamme, T.F. and K.J. Ellis, 2004. Issues and challenges in developing ruminal drug delivery systems.Adv. Drug Deliv. Rev., 56: 1415-1436.
6. Chien, Y.W., 1982. Fundamentals of controlled- release of drug administration. In: Swarbrick J. ed. Novel Drug Delivery System, Marcel Dekker, Inc. New York, pp: 465-574.
7. Buri, P., F. Puisicux, E. Doelker and J.P. Benoit, 1985. Formes Pharma centiques Nouvelles, ed. Technique et Documentation, Lavoisier, Paris
8. Jayanthi, B., P.K. Manna, S. Madhusudhan, G.P. Mohanta and R. Manavalam, 2011. Per oral extended releases products-an overview. Journal of Applied Pharmaceutical Science, 1(2): 50-5.
9. Ummadi, S.B., N.G. Shravani, M. Raghavendra Rao, Srikanth Reddy and B. Sanjeev Nayak, 2013. Overview on Controlled Release Dosage Form. International Journal of Pharma Sciences, 3(4): 258-269.
10. Gauri, B., K. Singh Shailendra and Mishra Dinanath, 2011. Formulation and evaluation of colon targeted oral drug delivery systems for metronidazole in treatment of amoebiasis. International Journal of Drug Delivery, 3: 503-512.
11. Lee, L., 1992. Diffusion-controlled matrix systems. In: Kydonieus A. ed. Treatise on Controlled Drug Delivery, Marcel Dekker, Inc. New York, pp: 155- 98.
12. Peppas, N.A., 1988. Hydrogels in Medicine and Pharmacy, vols. I, II and III, CRC Press, Boca Raton FL
13. Conte, U., P. Colombo, L. Maggi andA Manna La, 1994. Compressed barrier layers for constant drug release in swell able matrix tablets. STP Pharma Sci., 4: 107-113.
14. Jha, A.K., A. Bhattacharya and P. Verma, 2009. Formulation and in vitro evaluation of sustained release matrix tablets of metoprolol succinate using hydro philic polymers. International Journal of PharmTechResearch, 1(4): 972-77.
15. Prajapati, S.K., R. Richhaiya, V.K. Singh, A.K. Singh, S. Kumar and R.K. Chaudhary, 2012. Formulation and evaluation of once daily sustained release matrix tablet of aceclofenac using natural gums. Journal of Drug Delivery and Therapeutics, 2(1): 16-24.
16. Ganesh, S., M. Radhakrishnan, M. Ravi, B.Prasannat Kumar and J. Kalayani, 2008. In vitro evaluation of the effect of combination of hydrophilic and hydrophobic polymers on controlled release zidovudine matrix tablets. Indian J. Pharm Sci., 70(4): 461-5.
17. Enayatifard, R., M. Saeedi, J. Akbari and Y.H. Tabatabaee, 2009. Effect of hydroxypropyl methylcellulose and ethyl cellulose on release profile and kinetics of diltiazem HC1 from matrices. Tropical Journal of Pharmaceutical Research, 8(5): 425-32.
18. Derakhshandeh, K. and M. Soleymani, 2010. Formulation and in vitro evaluation of nifedipine- controlled release tablet: Influence of combination of hydrophilic and hydrophobic matrix forms. Asian Journal of Pharmaceutics, 4(4): 185-93.
19. Wadher, K.J., R.B. Kakde and M. Umekar, 2011. Formulation of sustained release metformin hydrochloride matrix tablets: Influence of hydrophilic polymers on the release rate and in vitro evaluation. International Journal of Research in Controlled Release, 1(1): 9-16.
20. Landgraf, W., N.H. Li and J.R. Benson, 2005. New polymer enables near zero order release of drugs. Drug Deliv. Technol., 5: 48-55.
21. Narasimaharao, R., R.M. Anusha, R.N. Swetha, P. Divyasagar and K. Keerthama, 2011. Design and evaluation of metformin hydrochloride extended release tablets by direct compression. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2(3): 1118-33.
22. Bhardwaj, L., P.K. Sharma and R. Malviya, 2011. A short review on gastro-retentive formulation for stomach specific drug delivery: Special emphasis on floating in situ gel systems. African Journal of Basic and Applied Sciences, 3(6): 300-12.
23. Shaikh, R.P., V. Pillay, Y.E. Choonara, L.C. Toit, V.M.K. Ndeseudo, P. Bawa and S Cooppan, 2010. A review on multi-responsive membranous systems for rate-modulated drug delivery. AAPS Phar. Sci. Tech., 11(1): 441-59.
24. Bansal, V., P.K. Sharma, N. Sharma, O.P. Pal and R Malviya, 2011. Applications of chitosan and chitosan derivatives in drug delivery. Advances in Biological Research, 5(1): 28-37.
25. Iqbal, Z., R. Khan, F. Nasir, J.A. Khan, A. Rashid and A. Khan, 2011. Preparation and in vitro in vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums. Pak. J. Pharm. Sci., 24(4): 435-43.
26. Goyel, M., R. Prajapati, K.K. Purohit and S.C. Mehta, 2011. Floating drug delivery system. Journal of Current Pharmaceutical Research, 5(1): 7-18.
27. Alderman, D., 1984. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms, Int. J. Pharm. Prod. Manuf, 5: 1-9.
28. Kim, C, 2005. Controlled release from triple layer, donut-shaped tablets with enteric polymers. AAPS Pharm Sci. Tech., 6(3): 429-36.
29. Efentakis, M. and S. Politis, 2006. Comparative evaluation of various structures in polymer controlled drug delivery systems and the effect of their morphology and characteristics on drug release. Eur. Polym. J.,42: 1183-1195.
30. Conte, U., L. Maggi, P. Colombo and L. Manna, 1993. Multilayered hydrophilic matrices as constant release devices. J. Control. Release, 26: 39-47.
31. Kim, C.J., 1999 Release kinetics of coated, donut-shaped tablets for water soluble drugs. Eur. J. Pharm. Sci., 12: 237-242.
32. Sham K. Chopra, 2003. Procise: Drug Delivery Systems Based on Geometric Configuration. Marcel
33. Patel, D., A.P.A. Tel and T. Solanki, 2012. Formulation and evaluation of bilayer tablet by using melt granulation technique for treatment of diabetes mellitus. Journal of Pharmacy and Bio Allied Sciences, 4(5): 37-9.
34. Shrikant, M., S. Shah and P. Upadhyay, 2012. Floating bilayer drug delivery systems-an unconventional approach in conventional form. American Journal of Pharm Tech Research, 2(2): 609-28.
35. Naeem, M.A., A. Mahmood, S.A. Khan and Z. Shahiq, 2010. Development and evaluation of controlled-release bilayer tablet containing microencapsulated tramadol and acetoaminophen. Tropical Journal of Pharmaceutical Research, 9(4): 347-54.
36. Negi, J.S., P. Khanduri, A. Trivedi, V. Negi and V. Singh, 2011. Effects of psylium husk on floating behavior of atenolol bilayer tablets. International Journal of Comprehensive Pharmacy, 4(6): 1-4.
37. Mehrgan, H. and S.A. Mortazavi, 2005. The release behavior and kinetic evaluation of diltiazem HC1 from various hydrophilic and plastic based matrices. Iranian Journal of Pharmaceutical Research, 4(3): 137-46.
38. Engineer, C, J. Parikh and A. Raval, 2011. Review on hydrolytic degradation behavior of biodegradable polymers from controlled drug delivery system. Trends Biomater. Artif. Organs, 25(2): 79-85
39. Fu, Y. and W.J. Kao, 2010. Drug release kinetics and transport mechanism of non-degradable and degradable polymeric drug delivery systems. Expert Opin Drug Deliv, 7(4): 429-44.
40. Moodley, K., V. Pillay, Y.E. Choonara, L.C. Du Toit, V.M.K.N. Desendo, P. Kumar, S. Cooppan and P. Bawa, 2012. Oral drug delivery systems comprising altered geometric configuration for controlled drug delivery. Int. J. Mol. Sci., 13(1): 18-43.
41. Rao, N.G.R., A. Yadav and U. Kulkarm, 2010. Formulation and evaluation of zero-order release glipizide bilayer matrix tablets using natural and synthetic polymers. International Journal of Current Pharmaceutical Research, 2(1): 34-42.
42. Sibambo, S.R. and V. Pillay, 2009. Kinetic and structural modeling mechanisms of melatonin transport from an electrolytically regulated salted out PLGA scaffold. Journal of Bioactive and Compatible Polymers, 24: 266-96.
43. Namdeo, B., 2008. Barrier layers in multilayered tablets. Express Pharma 2008. Available online: www.expresspharmaonline.com/20080731/researchO 3.shtml (accessed on 22 June 2013).
44. Abdul, S. and S.S. Poddar, 2004. A flexible technology for modified release of drugs: multi layered tablets. Journal of Controlled Release, 97: 393-405.
45. Ahmed, S.I., L.N. Mangamoori and Y.M. Rao, 2010. Formulation and characterization of matrix and triple-layer matrix tablets for oral controlled drug delivery. International Journal of Pharmacy and Pharmaceutical Sciences, 2(3): 137-43.
46. Qiu, Y., N. Chidambaram and K. Flood, 1998. Design and evaluation of layered diffusional matrices for zero-order sustained-release. J. Control. Release, 51: 123-130.
47. st edition, Vallabha prakashan, Delhi, pp: 267-347.
48. Brahmannkar,D.M. and S.B. Jaiswal, 1985. Controlled released medication, Biopharmaceutics and Pharmacokinetic, pp: 335-346.
49. Bhargava, A., R.P.S. Rathore, Y.S. Tanwar, S. Gupta and G. Bhaduka, 2013. Oral Sustained Release Dosage Form: An Opportunity to Prolong the Release of Drug. IJARPB. 3(1): 7-14.
50. Lachman Leon and A. Lieberman Herbert, 2002. Compression coated and layer tablets. In: Pharmaceutical Dosage Forms: Tablets. Marcel Dekker, Inc. New York, vol 1; 2nd Edition, pp: 247- 84.
51. Krishnaiah, Y. S.R., R. S Karthikeyan, P Bhaskar and V. Satyanarayana, 2002. Bioavailability studies on guar gum-based three-layer matrix tablets of trimetazidine dihydrochloride in human volunteer. J. Control. Release, 83: 231- 9.
52. Chidambaram, N., W. Porter, K. Flood and Y. Qiu, 1998. Formulation and characterization of new layered diffusional matrices for zero-order systained- release, J. Control. Release, 52: 149-158.
53. Maggi, L., S. Morgenthaler, R. Zimmer, T. Shepard and U. Conte, 1992. Human evaluation of Quick/Slow drug delivery technology: a new therapeutic approach, Proceedings of the 22nd International Symposium on Controlled Release of Bioactive Materails, Seattle, USA, pp: 208- 9.
54. Maggi, L., T. Shepard, M. Rochdi, P. Grenier, S. Halbeisen, R. Zimmer and U. Conte, 1997. A simulation approach for efficient development of a naproxen Geomatrix Quick/Slow formulation, Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials, Stockholm, Sweden, June 15- 19: 327-328
55. Maroni, A., L. Zema, M. Carea and M.E. Sangalli, 2005. Oral pulsatile drug delivery systems. Expert Opin Drug. Deliv., 2(5): 855-71.
56. Dalvadi, H. and J.K. Patel, 2010. Chrnopharmaceutics, pulsatile drug delivery system as current trend. Asian Journal of Pharmaceutical Sciences, 5(5): 207-30.
57. Shah, A.C., 1987. Therapeutic formulations with bimodal release characteristics, W.O. Patent 87/00044.
58. Shah, A.C., N.J.L.S. Britten and J.N. Olanoff, 1989. Badalamenti, Gelmatrix system exhibiting bimodal controlled-release for oral drug delivery, J. Control. Release, 9: 169- 175.
59. Vinayagamkannan, Ragupathikandarapu and S.Garg, 2003. Optimization techniquies for the design and development of novel drug delivery systems- part I. Pharm. Technol, 27(2): 74-90.
60. Vinayagamkannan, Ragupathikandarapu and S. Garg, 2003. Optimization techniquies for the design and development of novel drug delivery systems- part II. Pharm. Technol, 27(3): 102-18.
61. Davis, S.S.J.G. Hardy and J.W.Fara, 1986. Transit of pharmaceutical dosage forms through the small intestine. Gut, 27: 886- 92.
62. Rane, A.B., S.G. Gattani, V.D. Kadam and A.R. Tekade, 2009. Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers. Chem Pharm Bull, 57(11): 1213-7.
63. Streubel, A., A. Jsiepmann, N.A. Peppas and R. Bodmeier, 2000. Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design, J. Control. Release, 69: 455-468.
64. Fukui, E., N. Miyamura and M. Kobayashi, 2001. An in vitro investigation of the suitability of press- coated tablets with hydroxypropylmethylcellulose acetate succinate (HPMCAS) and hydrophobic additives in the outer shell for colon targeting. J. Control. Release, 70: 97- 107.
65. Cremer, K. and B.Asmussen, 1995. Novel Controlled- release tablet with erodible layers. Proc. Int. Control. Release Bioact. Mater, 22: 732-3.
66. Conte, U. and L. Maggi, 1996. Modulation of the dissolution profiles horn Geomatrix multi-laver matrix tablets containing drugs solubility. European J. Bio., 17: 889-896.
67. Chavda, H.V., M.S. Patel and C.N. Patel, 2012. Preparation and in vitro evaluation of guar gum based triple-layer matrix tablet of diclofenac sodium. Research Pharm. Sci., 7(1): 57-64.
68. Ahmed, S.I., M.L. Narsu and Y.M. Rao, 2011. Formulation and Characterization of Matrix and Triple-Layer matrix tablets for Controlled Delivery of Metoprolol tartrate. Int. J. Pharm. Sci and Drug. Research, 3(1): 23-28.
69. Libo Yang, Gopi Venkatesh and Reza Fassihi, 1997. Compaction simulator study of a novel triple-layer tablet matrix for industrial tableting. Int. J. Pharm, 2(3): 45-52.
70. Efentakis, M. and C. Peponaki, 2008. Formulation Study and Evaluation of Matrix and Three-layer Tablet Sustained Drug Delivery Systems Based on Carbopols with Isosorbite Mononitrate. AAPS Pharm. Sci. Tech., 9(3): 917-923.
71. Al-Saidan, S.M., Y.S.R Krishnaiah, V. Satyanarayana, P. Bhaskar andR.S. Karthikeyan, 2004. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug. European J. Pharm and Biopharm. 58: 697-703.
72. Krishnaiah, Y.S.R., S. Karthikeyan, V.S. Goun and V. Satyanarayana, 2002. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride. J. Control. Release, 81: 45-56.
73. Conte, L. and Maggi, 1993. Multi-layered hydrophilic matrices as constant release devices (Geomatrix™ Systems), J Control Release, 26(1): 39-47.
74. Dressman, J.B. and D. Fleisher, 1986. Mixing-tank model for predicting dissolution rate control or oral absorption. J. Pharm Sci., 75(2): 109-16.
75. Ozturk, S.S., B.O. Palsson, B. Do Nohoe and J.B. Dressman, 1988. Kinetics of release from enteric- coated tablets. Pharm Res., 5(9): 550-65.
76. Dressman, J.B., D. Fleisher and G.L. Amidon, 1984. Physicochemical model for dose-dependent drug absorption. J. Pharm Sci., 73(9): 1274-9.
77. Mauger, J.W., D. Chilko and S. Howard, 1986. On the analysis of the dissolution data, Drug Dev. Ind. Pharm. 12: 969-992.
78. Polli,J.E.,G.S.Rekhi,L.L. Augsburger and V.P. Shah, 1997. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartarate tablets, J. Pharm. Sci., 86: 690-700.
79. Costa, P. and J.M.S. Lobo, 2001. Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci., 13: 123-133.
80. Shah, V.P., L.J. Lesko, J. Fan, N. Fleischer, J. Handerson, H. Malinowski, M. Makary, L. Ouderkisk, S. Roy, P.S. Athe, G.J.P. Singh, L. Tillman, Y. Tsong and R.L. Williams, 1997. FDA guidance for industry: dissolution testing of immediate release solid orla dosage forms, Dissolution Technol., 4: 15-22.
81. Costa, P., 2001. An alternative method to the evaluation of similarity factor in dissolution testing, Int. J. Pharm. 220: 77-83.
82. Moore, J.W. and H.H. Flanner, 1996. Mathematical comparison of dissolution profiles, Pharm. Technol., 20: 64-74.
83. Guideline For Industry. 1995. Immediate Release solid oral dosage forms scale-up postapproval changes (SUPAC) In vitro dissolution testing, US Department of Health and Human Services, Food and Drug Administration
84. Dash, S., P.N. Murthy, L. Nath and P. Chowdhury, 2010. Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems. Acta Poloniae Pharmaceutica n Drug Research, 67(3): 217-223.
85. Gohel, M., M. Panchal and V. Jogani. 2000. Novel mathematical method for quantitative expression of deviation from the Higuchi model. AAPS Pharm Sci. Tech., 1:43-48.
86. Gautam, S. andM. Singh, 2011. Review: In-Vitro Drug Release Characterization Models. International Journal of Pharmaceutical Studies and Research, II(I): 77-84.
87. Korsmeyer, R.W., R. Gurny, E. Doelker, P. Buri and N.A. Peppas, 1983. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm, 15:25-35.